CClinicalTrials.gg
RecruitingNCT06808854Updated Jul 1, 2025

Variable-thread Versus Standard Dental Implants for Replacing Missing Teeth

An interventional study of Dental implant treatment (variable-thread implants) and Dental implant treatment (standard implants) in Dental Implants, sponsored by Mohammed Bin Rashid University of Medicine and Health Sciences. Recruiting at 1 site in United Arab Emirates. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-01.

Sponsored by Mohammed Bin Rashid University of Medicine and Health Sciences · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Background and objectives:

Primary and secondary implant stability remain the most relevant and reliable clinical indicator for long-term survival of dental implants. Hence modifications of surface characteristics and implant macro-designs were introduced over the last two decades to enhance osseointegration during the initial phase of healing. In this context, a variable-thread self-cutting implant design was recently introduced to improve primary stability. At present, there are limited number of studies that evaluated this variable-thread implant design. These studies were mostly experimental, of short duration and limited number of participants. Therefore, the aim of the present randomized controlled trial is to compare two implant designs (variable-thread versus standard) in terms of clinical, radiographic and patient-reported outcomes.

Methods:

A total of 24 participants, who require replacement of a posterior single tooth with dental implant, will be randomly allocated to two equal sized groups. In the test group, the participants will receive variable-thread implants, while standard implants will be placed to replace missing teeth in the control group. In addition to evaluating implant stability, the trial will also report on clinical and radiographic implant outcomes at various time points.

Read the detailed description

Introduction

Implant stability is a prerequisite for successful osseointegration and implant survival as implant micro-motion can compromise osseointegration and lead to implant failure. Maintenance of implant stability over time has been considered one of the implant success criteria that is identified at the primary or secondary level. Primary implant stability occurs as a result of bone compression and mechanical interlocking between implant surface and bone at the time of implant placement. Therefore, primary stability can be largely influenced by implant surface characteristics and implant design in terms of microstructure, thread design and geometry as well as bone quality and quantity. In contrast, secondary implant stability is a biologically mediated process by which bone matures and remodels at the bone-implant interface.

Primary and secondary implant stability remain the most relevant and reliable clinical indicator for long-term survival of dental implants. Hence modifications of surface characteristics and implant macro-designs were introduced over the last two decades to enhance osseointegration during the initial phase of healing. In this context, an implant design was recently introduced to improve primary stability particularly in areas of poor bone quality such as the posterior maxilla. The recently introduced implant has self-cutting self-drilling body with variable thread configurations that are designed to allow controlled compaction and condensation of bone during insertion thus enhancing the initial bone to implant contact. It is claimed that high primary stability is achieved by a controlled bone compaction and densification mechanism resulting from the double variable thread design and the apical sharp threads. In addition, the implant is made up of titanium-zirconium alloy that provide strength, high resistance to loading and biocompatibility. Its moderately rough hydrophilic sandblasted and acid-etched (SLActive) surface can also improve bone-implant contact during the early phase of osseointegration.

At present, there are limited number of studies that evaluated this variable-thread implant design. These studies were mostly experimental, of short duration and limited number of participants. Therefore, the aim of the present randomized controlled trial is to compare two implant designs (variable-thread versus standard) in terms of clinical, radiographic and patient-reported outcomes.

Objectives:

The aims of the present randomized controlled trial are:

  • To evaluate implant stability.
  • To evaluate the changes in peri-implant marginal bone level.
  • To evaluate implant survival rates.
  • To evaluate biological and technical complications during the follow-up period.
02

Conditions studied

  • Dental Implants
03

In context

Lead sponsor

Mohammed Bin Rashid University of Medicine and Health Sciences is the lead sponsor of 20 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion criteria

  • Aged more than 18 years.
  • Good general health (ASA I or II, according to the American Academy of Anesthesiology).
  • Require replacement of a posterior single missing tooth with a dental implant.
  • Controlled oral hygiene (full-mouth plaque and bleeding scores ≤ 25% at baseline.
  • Good compliance and commitment to attend follow-up review appointments.
  • Willing to provide informed consent. Exclusion criteria
  • A healing period of less than four months postextraction at implant site.
  • Localized/generalized periodontitis.
  • Bone metabolic disease and/or taking medications that affect bone metabolism.
  • Long term use of non-steroidal anti-inflammatory medications.
  • History of malignancy, radiotherapy or chemotherapy.
  • Pregnant or lactating women.
  • Severe bruxism or parafunctional habits.
  • Large occlusal discrepancies.
  • Smokers.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Variable-thread implants

    The placement of a variable-thread implant to replace single missing posterior tooth

    Procedure: Dental implant treatment (variable-thread implants)

  • Active comparator
    Standard implants

    The placement of standard implant to replace single missing posterior tooth

    Procedure: Dental implant treatment (standard implants)

Interventions

  • ProcedureDental implant treatment (variable-thread implants)

    Replacement of a missing tooth with a dental implant with variable-thread implants

  • ProcedureDental implant treatment (standard implants)

    Replacement of a missing tooth with a dental implant with standard implants

06

What researchers measure

Primary outcomes

  1. Implant stability measurements

    A resonance frequency analysis device will used to measure the stability of the dental implant. The measurements will be recorded The use of a resonance frequency analysis device involves the following steps: attach the sensor to the implant, activate the device to measure resonance frequency, read the implant stability quotient (ISQ) value displayed on the device.

    Time frame: "during implant placement procedure" "1 year" "up to 24 weeks" "through study completion, an average of 1 year".

Secondary outcomes

  1. Changes in peri-implant marginal bone level

    Changes in peri-implant marginal bone level will be assessed using standardized peri-apical radiograph

    Time frame: "during implant placement procedure" "1 year" "up to 24 weeks" "through study completion, an average of 1 year".

  2. Implant survival rate

    Implant survival rate will be assessed clinically after one year of implant restoration and annually up to three years. Unlike other measurements, implant survival, defined as a dental implant that remains in place and functional, will be only assessed once a year.

    Time frame: "1 year" "up to 24 weeks" "through study completion, an average of 1 year".

  3. Biological and technical complications

    Biological and technical complications will be recorded during the follow-up period

    Time frame: "1 year" "up to 24 weeks" "through study completion, an average of 1 year".

07

Study locations

1 of 1 sites recruiting
  • MBRU
    Dubai, United Arab Emirates
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06808854
Lead sponsor
Mohammed Bin Rashid University of Medicine and Health Sciences
Responsible party
Momen Atieh (Professor and Chair (Periodontology), Mohammed Bin Rashid University of Medicine and Health Sciences) — Principal investigator
First posted
Feb 5, 2025
Start date
Aug 1, 2025 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Nov 1, 2027 (estimated)
Last update
Jul 1, 2025

Study contacts

Momen Atieh, BDS, MSc, DClinDent, PhD
Contact
momen.atieh@mbru.ac.ae
+9714 383 8905

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion